NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 208 filers reported holding NEKTAR THERAPEUTICS in Q3 2017. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $17,960,000 | +4.7% | 1,000,000 | 0.0% | 0.58% | +37.2% |
Q2 2021 | $17,160,000 | -14.2% | 1,000,000 | 0.0% | 0.42% | -3.6% |
Q1 2021 | $20,000,000 | +198.3% | 1,000,000 | +222.0% | 0.44% | +123.9% |
Q4 2019 | $6,704,000 | -94.7% | 310,579 | -74.0% | 0.20% | -97.2% |
Q1 2018 | $126,694,000 | +15.7% | 1,192,300 | -35.0% | 7.00% | +26.8% |
Q4 2017 | $109,526,000 | +291.4% | 1,834,000 | +57.3% | 5.52% | +333.7% |
Q3 2017 | $27,986,000 | +22.8% | 1,166,100 | 0.0% | 1.27% | +4.3% |
Q2 2017 | $22,797,000 | +45.9% | 1,166,100 | +75.2% | 1.22% | +19.1% |
Q1 2017 | $15,622,000 | +58.9% | 665,600 | +16.3% | 1.02% | +18.0% |
Q3 2016 | $9,829,000 | +36.4% | 572,100 | -12.7% | 0.87% | -5.1% |
Q1 2015 | $7,205,000 | -29.0% | 655,000 | 0.0% | 0.92% | -7.9% |
Q4 2014 | $10,153,000 | – | 655,000 | – | 1.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 5,000,000 | $82,950,000 | 2.19% |
MAVERICK CAPITAL LTD | 5,678,221 | $94,202,000 | 1.75% |
Rhenman & Partners Asset Management AB | 1,000,000 | $16,590,000 | 1.48% |
Goodman Financial Corp | 119,198 | $1,977,000 | 0.92% |
Bellevue Group AG | 3,632,358 | $60,261,000 | 0.83% |
OSTERWEIS CAPITAL MANAGEMENT INC | 477,004 | $7,914,000 | 0.53% |
Parametrica Management Ltd | 13,658 | $226,000 | 0.43% |
RICE HALL JAMES & ASSOCIATES, LLC | 592,930 | $9,837,000 | 0.40% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,000 | $1,110,000 | 0.36% |
Burleson & Company, LLC | 92,836 | $1,617,000 | 0.31% |